New heart pump trial offers hope for severe heart failure patients

NCT ID NCT05291884

Ongoing Disease control Sponsor: Abiomed Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a temporary heart pump called Impella BTR in 10 adults with severe heart failure. The pump is placed inside the body to help the heart pump blood for up to 28 days. The goal is to see if the device is safe and can support patients until they recover or receive another treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE DECOMPENSATED HEART FAILURE HEART FAILURE

Contacts and locations

Locations

Cleveland Clinic

Cleveland, Ohio, 44195, United States
Emory University Hospital

Atlanta, Georgia, 30322, United States
Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Northwestern University

Evanston, Illinois, 60208, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.